JAM3 Antikörper (FITC)
(1 reference)Kurzübersicht für JAM3 Antikörper (FITC) (ABIN2475172)
Target
Alle JAM3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Kreuzreaktivität
- Human
-
Produktmerkmale
- Purified IgG conjugated to Fluorescein Isothiocyanate Isomer 1 (FITC)
-
Immunogen
- Recombinant soluble JAM-C
-
Isotyp
- IgG2a
-
-
anti-Junctional Adhesion Molecule 3 (JAM3) (AA 119-235) antibody
JAM3 Reaktivität: Human WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Junctional Adhesion Molecule 3 (JAM3) (AA 1-310) antibodyJAM3 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Junctional Adhesion Molecule 3 (JAM3) (AA 31-130) antibodyJAM3 Reaktivität: Human, Maus, Ratte WB, ELISA, IHC (fro), IF (cc), IF (p), ICC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Junctional Adhesion Molecule 3 (JAM3) (AA 261-295), (C-Term) antibodyJAM3 Reaktivität: Human, Maus, Ratte WB Wirt: Kaninchen Polyclonal RB47643 unconjugated
anti-Junctional Adhesion Molecule 3 (JAM3) antibodyJAM3 Reaktivität: Human, Maus FACS, IF, IHC (fro) Wirt: Ratte Monoclonal CRAM-18 F26 unconjugated
anti-Junctional Adhesion Molecule 3 (JAM3) (AA 82-180) antibodyJAM3 Reaktivität: Human ELISA Wirt: Maus Monoclonal 1D3 unconjugated
anti-Junctional Adhesion Molecule 3 (JAM3) (AA 36-85) antibodyJAM3 Reaktivität: Human, Maus, Meerschweinchen, Affe WB Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.1 mg/mL
-
-
-
: "JAM-2, a novel immunoglobulin superfamily molecule, expressed by endothelial and lymphatic cells." in: The Journal of biological chemistry, Vol. 276, Issue 4, pp. 2733-41, (2001) (PubMed).
-
: "JAM-2, a novel immunoglobulin superfamily molecule, expressed by endothelial and lymphatic cells." in: The Journal of biological chemistry, Vol. 276, Issue 4, pp. 2733-41, (2001) (PubMed).
-
-
